2496 — Wuhan YZY Biopharma Share News
0.000.00%
Last trade - 00:00- HK$736.63m
- HK$810.17m
- CNY66.86m
Brief: Wuhan Yzy Biopharma Co Says NDA For M701 Accepted By NMPA For Treatment Of Malignant Ascites
Brief: Wuhan Yzy Biopharma Says M701 Receives IND Approval From FDA
Brief: Wuhan YZY Biopharma Says Wuhan Yiruide To Buy Land Use Right And Building
Brief: Wuhan Yzy Biopharma Says Y225 Receives IND Approval From NMPA
Brief: Wuhan YZY Biopharma Sees Decrease In Consolidated Loss By No Less Than 35% For Year
Brief: Wuhan YZY Biopharma Announces License & Collaboration Agreement With CT Tianqing
Brief: Wuhan Yzy Biopharma Posts FY Loss Of RMB191.7 Mln
Brief: Wuhan YZY Biopharma Says Over-Allotment Option Partially Exercised